Your SlideShare is downloading. ×
0
PRAMI Trial

Abdelkader Almanfi, MD, MRCP-UK
Texas Heart Institute
Journal club
11/04/2013
Disclosure

I have nothing to disclose except that I am getting free
lunches, books, dinners and courses from countless nu...
Original Article
Randomized Trial of Preventive Angioplasty
in Myocardial Infarction
David S. Wald, M.D., Joan K. Morris, ...
Study Overview
• Patients with acute STEMI were randomly assigned
to undergo infarct-vessel-only PCI or preventive
PCI (PC...
Enrollment and Follow-up.

Wald DS et al. N Engl J Med 2013;369:1115-1123
Kaplan–Meier Curves for the Primary Outcome.

Wald DS et al. N Engl J Med 2013;369:1115-1123
Characteristics of the Patients at Baseline.

Wald DS et al. N Engl J Med 2013;369:1115-1123
Details Regarding PCI and Medical Therapy at Discharge.

Wald DS et al. N Engl J Med 2013;369:1115-1123
Prespecified Clinical Outcomes.

Wald DS et al. N Engl J Med 2013;369:1115-1123
Conclusions

• In patients with STEMI and multi-vessel
coronary artery disease undergoing infarctartery PCI, preventive PC...
Critics about the study:

- Sample size is small
-Larger number of patients were inferior infarcts
- EF was not reported i...
What does the guidelines say about PCI in
STEMI and how the question of noninfarct artery
PCI was addressed in 2013 guidel...
Primary PCI in STEMI

I

IIa

IIb

III

Primary PCI should be performed in patients with
STEMI and ischemic symptoms of le...
Primary PCI in STEMI

I

IIa

IIb

III

Primary PCI is reasonable in patients with STEMI if
there is clinical and/or ECG e...
Primary PCI in STEMI
PCI of a Noninfarct Artery Before Hospital Discharge:
Recommendations
CLASS I
1. PCI is indicated in a noninfarct artery a...
Multivessel coronary artery disease is present in 40% to 65%
of patients presenting with STEMI who undergo primary PCI
and...
The largest of these observational studies compared 538 patients
undergoing staged multivessel PCI within 60 days of prima...
Although fractional flow reserve is evaluated infrequently in
patients with STEMI, at least 1 study suggests that
determin...
Prognostic Impact of Staged vs. “Onetime”
Multivessel PCI in AMI
Retrospective analysis of 668 pts from HORIZONS-AMI

• On...
Culprit Vessel Only vs. Multivessel and
Staged PCI for Multivessel Disease in
STEMI Patients
Meta-analysis of 4 prospectiv...
Multivessel Coronary Artery Revascularization vs.
Culprit-Only Revascularization in STEMI Patients
Meta-analysis of 19 stu...
55 YO male, initial presentation of CAD
Anterior STEMI – 6 hours of chest pain

ECG: Ant. ST Elevation with RBBB
 100/...
55YO male, initial presentation of CAD
Anterior STEMI – 6 hours of chest pain

ECG: Ant. ST Elevation with RBBB
 100/7...
Why to perform non-culprit
PCI
• Improve hemodynamics
– Hypercontraction of non-infarct territory (especially
important in...
Why not to perform nonculprit PCI (1)

Ischemic complications may lead to
severe hemodynamic compromise

There is alread...
Why not to perform nonculprit PCI (2)

Contrast nephropathy

Increased contrast load in the setting of
unknown kidney fu...
US National Cardiovascular Data Registry - STEMI
Single vs. Multivessel Procedures during Primary PCI

Hospital Mortality
...
 Four prospective and 14
retrospective studies
involving 40,280 patients
were included
 Pairwise comparison
among 3 post...
Short Term Mortality – Pairwise Meta-Analysis

Prospective RCT

Registry

Prospective and retrospective data
lead to diffe...
Conclusions
 Retrospective studies are strongly limited by
selection bias and prospective randomized
studies are small an...
Back to the Patient

“individualized” decision for this patient:

Stent the non-culprit first to enable
safer treatment o...
Final Result
Thanks
Upcoming SlideShare
Loading in...5
×

PRAMI clinical trial (for STEMI intervention)

2,213

Published on

Published in: Technology, Business
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
2,213
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
158
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

Transcript of "PRAMI clinical trial (for STEMI intervention)"

  1. 1. PRAMI Trial Abdelkader Almanfi, MD, MRCP-UK Texas Heart Institute Journal club 11/04/2013
  2. 2. Disclosure I have nothing to disclose except that I am getting free lunches, books, dinners and courses from countless number of companies. But for sure, No cash money or checks involved (yet)
  3. 3. Original Article Randomized Trial of Preventive Angioplasty in Myocardial Infarction David S. Wald, M.D., Joan K. Morris, Ph.D., Nicholas J. Wald, F.R.S., Alexander J. Chase, M.B., B.S., Ph.D., Richard J. Edwards, M.D., Liam O. Hughes, M.D., Colin Berry, M.B., Ch.B., Ph.D., Keith G. Oldroyd, M.D., for the PRAMI Investigators N Engl J Med Volume 369(12):1115-1123 September 19, 2013
  4. 4. Study Overview • Patients with acute STEMI were randomly assigned to undergo infarct-vessel-only PCI or preventive PCI (PCI to noninfarct arteries with stenoses). • The rate of the primary outcome of cardiac death, myocardial infarction, or refractory angina was lower with preventive PCI.
  5. 5. Enrollment and Follow-up. Wald DS et al. N Engl J Med 2013;369:1115-1123
  6. 6. Kaplan–Meier Curves for the Primary Outcome. Wald DS et al. N Engl J Med 2013;369:1115-1123
  7. 7. Characteristics of the Patients at Baseline. Wald DS et al. N Engl J Med 2013;369:1115-1123
  8. 8. Details Regarding PCI and Medical Therapy at Discharge. Wald DS et al. N Engl J Med 2013;369:1115-1123
  9. 9. Prespecified Clinical Outcomes. Wald DS et al. N Engl J Med 2013;369:1115-1123
  10. 10. Conclusions • In patients with STEMI and multi-vessel coronary artery disease undergoing infarctartery PCI, preventive PCI in non-infarct coronary arteries with major stenoses significantly reduced the risk of adverse cardiovascular events, as compared with PCI limited to the infarct artery.
  11. 11. Critics about the study: - Sample size is small -Larger number of patients were inferior infarcts - EF was not reported in the study
  12. 12. What does the guidelines say about PCI in STEMI and how the question of noninfarct artery PCI was addressed in 2013 guidelines ?
  13. 13. Primary PCI in STEMI I IIa IIb III Primary PCI should be performed in patients with STEMI and ischemic symptoms of less than 12 hours’ duration. I IIa IIb III Primary PCI should be performed in patients with STEMI and ischemic symptoms of less than 12 hours’ duration who have contraindications to fibrinolytic therapy, irrespective of the time delay from FMC. I IIa IIb III Primary PCI should be performed in patients with STEMI and cardiogenic shock or acute severe HF, irrespective of time delay from MI onset.
  14. 14. Primary PCI in STEMI I IIa IIb III Primary PCI is reasonable in patients with STEMI if there is clinical and/or ECG evidence of ongoing ischemia between 12 and 24 hours after symptom onset. I IIa IIb Harm III PCI should not be performed in a noninfarct artery at the time of primary PCI in patients with STEMI who are hemodynamically stable
  15. 15. Primary PCI in STEMI
  16. 16. PCI of a Noninfarct Artery Before Hospital Discharge: Recommendations CLASS I 1. PCI is indicated in a noninfarct artery at a time separate from primary PCI in patients who have spontaneous symptoms of myocardial ischemia. (Level of Evidence: C) CLASS IIa 1. PCI is reasonable in a noninfarct artery at a time separate from primary PCI in patients with intermediate- or high-risk findings on noninvasive testing. (Level of Evidence: B)
  17. 17. Multivessel coronary artery disease is present in 40% to 65% of patients presenting with STEMI who undergo primary PCI and is associated with adverse prognosis. Studies of staged PCI of noninfarct arteries have been nonrandomized in design and have varied with regard to the timing of PCI and duration of follow-up. These variations have contributed to the disparate findings reported, although there seems to be a clear trend toward lower rates of adverse outcomes when primary PCI is limited to the infarct artery and PCI of a noninfarct artery is undertaken in staged fashion at a later time.
  18. 18. The largest of these observational studies compared 538 patients undergoing staged multivessel PCI within 60 days of primary PCI with propensity-matched individuals who had culprit-vessel PCI alone. Multivessel PCI was associated with lower mortality rate at 1 year (1.3% versus 3.3%; p0.04). A none significant trend toward a lower mortality rate at 1 year was observed in the subset of 258 patients who underwent staged PCI during the initial hospitalization for STEMI.
  19. 19. Although fractional flow reserve is evaluated infrequently in patients with STEMI, at least 1 study suggests that determination of fractional flow reserve may be useful to assess the hemodynamic significance of potential target lesions in noninfarct arteries. The writing committee encourages research into the benefit of PCI of noninfarct arteries in patients with multivessel disease after successful primary PCI
  20. 20. Prognostic Impact of Staged vs. “Onetime” Multivessel PCI in AMI Retrospective analysis of 668 pts from HORIZONS-AMI • One-time multivessel PCI was associated with higher rates of all-cause and cardiac mortality as well as stent thrombosis compared with staged PCI • The mortality advantage was maintained in a subgroup of pts undergoing „truly elective‟ multivessel PCI • In multivariable analysis, staged vs. onetime PCI was an independent predictor of 1-year mortality Implications: Deferred angioplasty of significant nonculprit lesions should be the default strategy for patients undergoing primary PCI. Kornowski R, et al. J Am Coll Cardiol. 2011;58:704-711.
  21. 21. Culprit Vessel Only vs. Multivessel and Staged PCI for Multivessel Disease in STEMI Patients Meta-analysis of 4 prospective and 14 retrospective studies (n = 40,280) Staged PCI was associated with lower short- and long-term mortality compared with culprit-vessel-only and multivessel PCI Multivessel PCI was linked to the highest mortality rates at both short- and long-term follow-up The best strategy in pts with cardiogenic shock remains uncertain Implications: In STEMI pts, significant nonculprit lesions should be treated only during staged procedures, a finding that supports guidelines. Vlaar PJ, et al. J Am Coll Cardiol. 2011;58:692-703.
  22. 22. Multivessel Coronary Artery Revascularization vs. Culprit-Only Revascularization in STEMI Patients Meta-analysis of 19 studies (n = 61,764), including 2 randomized trials. • Within 30 days, there was no difference between groups for mortality, MI, stroke, and TVR, but multivessel PCI decreased repeat PCI by 44% and MACE by 32% • Over mean follow-up of 2 years, there was no difference between groups for MI, TVR, or stent thrombosis, but multivessel PCI lowered mortality by 33%, repeat PCI by 43%, and MACE by 40% Implications: A large-scale randomized trial is needed to evaluate comparative efficacy between multivessel revascularization and a culprit-only strategy. Bangalore S, et al. Am J Cardiol. 2011;Epub ahead of print.
  23. 23. 55 YO male, initial presentation of CAD Anterior STEMI – 6 hours of chest pain  ECG: Ant. ST Elevation with RBBB  100/70, pulse 95, O2Sat =96% BP .T otal LAD • Culprit • >90% Prox. CX • Dominant • 50% Left Main Small (non dominant) RCA
  24. 24. 55YO male, initial presentation of CAD Anterior STEMI – 6 hours of chest pain  ECG: Ant. ST Elevation with RBBB  100/70, pulse 95, O2Sat =96% BP What to do? 1. Culprit only (LAD) 2. LAD and CX 3. LAD now and CX later (Staging) • When? 4. Other Small (non dominant) RCA
  25. 25. Why to perform non-culprit PCI • Improve hemodynamics – Hypercontraction of non-infarct territory (especially important in patients with cardiogenic shock) • Prevent reinfarction – Vulnerable non-culprit lesion can become culprit (“pan-coronary inflammation”) • Patient is already receiving aggressive antithrombotic therapy – Protected from complications? • Decrease the need for repeat procedures – Associated morbidity and cost
  26. 26. Why not to perform nonculprit PCI (1)  Ischemic complications may lead to severe hemodynamic compromise  There is already myocardial dysfunction secondary to the damage from the culprit  There is a risk of ischemic complication in every PCI  Risk is higher in the setting of MI due to the generalized inflammatory condition  Risk of transformation to culprit during hospitalization is extremely low  Patient receiving aggressive adjunct therapy
  27. 27. Why not to perform nonculprit PCI (2)  Contrast nephropathy  Increased contrast load in the setting of unknown kidney function in a patient with decreased renal blood flow (due to the infarction)  Non culprit lesion may not be associated with future symptoms/ ischemia  Overestimation of severity at time of acute angiography?
  28. 28. US National Cardiovascular Data Registry - STEMI Single vs. Multivessel Procedures during Primary PCI Hospital Mortality Unadjusted Data % death P= 0.01 Guidelines not necessarily supported by literature P< 0.01 Cavender et al. Am J Cardiol 2009
  29. 29.  Four prospective and 14 retrospective studies involving 40,280 patients were included  Pairwise comparison among 3 post culprit PCI strategies: 1. Culprit only 2. Staged revascularization 3. Complete revascularization J Am Coll Cardiol 2011;58:692–703
  30. 30. Short Term Mortality – Pairwise Meta-Analysis Prospective RCT Registry Prospective and retrospective data lead to different results Suggestive of significant selection bias Combined Culprit Multivessel
  31. 31. Conclusions  Retrospective studies are strongly limited by selection bias and prospective randomized studies are small and inconclusive  Staged revascularization emerges as the preferred approach for stable patients  Non-culprit revascularization strategy should be individualized based on patient‟s characteristics
  32. 32. Back to the Patient “individualized” decision for this patient:  Stent the non-culprit first to enable safer treatment of the LAD lesion  Limited reserve due to the specific anatomy
  33. 33. Final Result
  34. 34. Thanks
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×